Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDPK1 | O15530 | 1/20 | 0.66 |
| ▸ | CA1 | P00915 | 1/20 | 0.61 |
| ▸ | CA2 | P00918 | 1/20 | 0.61 |
| ▸ | MAOA | P21397 | 4/20 | 0.54 |
| ▸ | MAOB | P27338 | 4/20 | 0.54 |
| ▸ | BCHE | P06276 | 1/20 | 0.54 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.54 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.54 |
| ▸ | ACHE | P22303 | 1/20 | 0.54 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.54 |
| ▸ | HTR6 | P50406 | 1/20 | 0.54 |
| ▸ | FADS1 | O60427 | 1/20 | 0.54 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.51 |
| ▸ | KDM1A | O60341 | 1/20 | 0.51 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.47 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.47 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13618841 | 1.00 | PDPK1 (0.66) | PDPK1CA1CA2MAOAMAOB | |
| SCHEMBL8824939 | 0.88 | ALDH1A1 (0.58) | PDPK1ADRA2BADRA2CADRA1ATAS1R3 | |
| SCHEMBL3539943 | 0.88 | ALDH1A1 (0.58) | PDPK1ADRA2BADRA2CADRA1ATAS1R3 | |
| SCHEMBL2322457 | 0.83 | PDPK1 (0.70) | PDPK1CA1CA2MAOAMAOB | |
| Hydrochloric Acid SCHEMBL7123292 | 0.81 | PDPK1 (0.68) | PDPK1CA1CA2MAOAMAOB | |
| SCHEMBL6337843 | 0.80 | CA1 (0.71) | PDPK1CA1CA2MAOAMAOB | |
| SCHEMBL19508305 | 0.79 | PDPK1 (0.66) | PDPK1CA1CA2MAOAMAOB | |
| SCHEMBL20354303 | 0.79 | PDPK1 (0.66) | PDPK1CA1CA2MAOAMAOB | |
| SCHEMBL61508 | 0.79 | PDPK1 (1.00) | PDPK1CA1CA2MAOAMAOB | |
| SCHEMBL2321988 | 0.79 | PDPK1 (0.66) | PDPK1CA1CA2MAOAMAOB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110218361-A1 | METHOD FOR PRODUCING COMPOUND FOR PREPARATION OF ANTI-PARKINSON'S DISEASE DRUG | EVERLIGHT USA, INC. (US) | 2011-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110218361-A1 | METHOD FOR PRODUCING COMPOUND FOR PREPARATION OF ANTI-PARKINSON'S DISEASE DRUG | PARK7, RAB35, RAB7A | PDPK1 814/4885CA1 4684/4885CA2 4750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.